SORL1 is a receptor for tau that promotes tau seeding.

SORL1 Tau protein (Tau) apolipoprotein E (ApoE) lipoprotein receptor-related protein (LRP) neurodegenerative disease tau seeding tauopathy

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
22 Apr 2024
Historique:
received: 05 01 2024
revised: 28 03 2024
accepted: 15 04 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 24 4 2024
Statut: aheadofprint

Résumé

Sortilin-related receptor 1 (SORL1) is an intracellular sorting receptor genetically implicated in Alzheimer's disease (AD) that impacts amyloid precursor protein trafficking. The objective of these studies was to test the hypothesis that SORL1 binds tau, modulates its cellular trafficking and impacts the aggregation of cytoplasmic tau induced by pathological forms of tau. Using surface plasmon resonance measurements, we observed high-affinity binding of tau to SORL1 and the vacuolar protein sorting 10 (VPS10) domain of SORL1. Interestingly, unlike LRP1, SORL1 binds tau at both pH 7.4 and pH 5.5, revealing its ability to bind tau at endosomal pH. Immunofluorescence studies confirmed that exogenously added tau colocalized with SORL1 in H4 neuroglioma cells, while overexpression of SORL1 in LRP1-deficient Chinese hamster ovary (CHO) cells resulted in a marked increase in the internalization of tau, indicating that SORL1 can bind and mediate the internalization of monomeric forms of tau. We further demonstrated that SORL1 mediates tau seeding when tau RD P301S FRET biosensor cells expressing SORL1 were incubated with high molecular weight forms of tau isolated from the brains of patients with AD. Seeding in H4 neuroglioma cells is significantly reduced when SORL1 is knocked down with siRNA. Finally, we demonstrate that the N1358S mutant of SORL1 significantly increases tau seeding when compared to WT SORL1, identifying for the first time a potential mechanism that connects this specific SORL1 mutation to Alzheimer's disease. Together, these studies identify SORL1 as a receptor that contributes to trafficking and seeding of pathogenic tau.

Identifiants

pubmed: 38657864
pii: S0021-9258(24)01814-3
doi: 10.1016/j.jbc.2024.107313
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107313

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Joanna M Cooper (JM)

The Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201.

Aurelien Lathuiliere (A)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA; Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospital and University of Geneva, Geneva, Switzerland.

Enming J Su (EJ)

Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.

Yuyu Song (Y)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA.

Daniel Torrente (D)

Patricia and John Rosenwald Laboratory of Neurobiology and Genetics, The Rockefeller University, New York, NY.

Youhwa Jo (Y)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA.

Nicholas Weinrich (N)

The Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201.

Jennifer Diaz Sales (JD)

The Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201.

Mary Migliorini (M)

The Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201.

Thomas H Sisson (TH)

Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.

Daniel A Lawrence (DA)

Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.

Bradley T Hyman (BT)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA. Electronic address: bhyman@mgh.harvard.edu.

Dudley K Strickland (DK)

The Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201; Departments of Physiology and University of Maryland School of Medicine, Baltimore, MD 21201; Departments of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201. Electronic address: dstrickland@som.umaryland.edu.

Classifications MeSH